Cargando…
A review of levosimendan in the treatment of heart failure
Heart failure is a relatively important public health problem due to its increasing incidence, poor prognosis, and frequent need of re-hospitalization. Intravenous positive inotropic agents play an important role in treating acute decompensation of patients with heart failure due to left ventricular...
Autores principales: | Kasikcioglu, Hulya Akhan, Cam, Nese |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1994023/ https://www.ncbi.nlm.nih.gov/pubmed/17323593 |
Ejemplares similares
-
Newer treatments for decompensated heart failure: focus on levosimendan
por: Follath, Ferenc
Publicado: (2009) -
Levosimendan in pulmonary hypertension and right heart
failure
por: Hansen, Mona Sahlholdt, et al.
Publicado: (2018) -
Evidence and Current Use of Levosimendan in the Treatment of Heart Failure: Filling the Gap
por: Conti, Nicolina, et al.
Publicado: (2021) -
Use of Levosimendan in Patients with Advanced Heart Failure: An Update
por: Masarone, Daniele, et al.
Publicado: (2022) -
Use of levosimendan in acute heart failure
por: Harjola, Veli-Pekka, et al.
Publicado: (2018)